ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,549.81
      1.08%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Tenaya Therapeutics Inc (TNYA)

      7. Tenaya Therapeutics Inc (TNYA) News

      TNYA

      Tenaya Therapeutics (TNYA)

      Tenaya Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TNYA
      DateTimeSourceHeadlineSymbolCompany
      12/07/20226:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TNYATenaya Therapeutics Inc
      12/07/20226:14PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TNYATenaya Therapeutics Inc
      12/07/20224:43PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TNYATenaya Therapeutics Inc
      12/07/20224:30PMGlobeNewswire Inc.Tenaya Therapeutics Appoints Amy Burroughs to Board of DirectorsNASDAQ:TNYATenaya Therapeutics Inc
      12/07/20221:52PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TNYATenaya Therapeutics Inc
      11/28/20229:27AMDow Jones NewsTenaya Receives FDA Orphan Drug Designation for TN-401 Cardiomyopathy TreatmentNASDAQ:TNYATenaya Therapeutics Inc
      11/28/20228:30AMGlobeNewswire Inc.Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular CardiomyopathyNASDAQ:TNYATenaya Therapeutics Inc
      11/24/20226:33AMTipRanksMassive Insider Trading of Tenaya (NASDAQ:TNYA) Stock Spikes Investors’ InterestNASDAQ:TNYATenaya Therapeutics Inc
      11/23/20224:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TNYATenaya Therapeutics Inc
      11/23/20229:00AMGlobeNewswire Inc.Tenaya Therapeutics to Participate in Upcoming Piper Sandler 34th Annual Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
      11/21/20225:45PMGlobeNewswire Inc.Tenaya Therapeutics Announces Closing of Public OfferingNASDAQ:TNYATenaya Therapeutics Inc
      11/17/20224:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TNYATenaya Therapeutics Inc
      11/17/20224:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TNYATenaya Therapeutics Inc
      11/17/20226:15AMTipRanksTenaya Therapeutics Tanks After Pricing of Public OfferingNASDAQ:TNYATenaya Therapeutics Inc
      11/17/202212:39AMGlobeNewswire Inc.Tenaya Therapeutics Announces Pricing of Public OfferingNASDAQ:TNYATenaya Therapeutics Inc
      11/16/20224:01PMGlobeNewswire Inc.Tenaya Therapeutics Announces Proposed Public OfferingNASDAQ:TNYATenaya Therapeutics Inc
      11/10/20224:31PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TNYATenaya Therapeutics Inc
      11/10/20224:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TNYATenaya Therapeutics Inc
      11/10/20224:05PMGlobeNewswire Inc.Tenaya Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
      11/04/20228:00AMGlobeNewswire Inc.Tenaya Therapeutics to Present Preclincial Study Data from TN-301 Program at the American Heart Association Scientific Sessions 2022NASDAQ:TNYATenaya Therapeutics Inc
      10/11/20229:04AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TNYATenaya Therapeutics Inc
      10/04/20228:30AMGlobeNewswire Inc.Tenaya Therapeutics to Present Preclinical Data on Its Novel Engineered AAV Capsids for Cardiac Gene Delivery at the ESGCT 29th Annual CongressNASDAQ:TNYATenaya Therapeutics Inc
      09/29/20228:00AMGlobeNewswire Inc.Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Society’s 2022 Scientific SessionsNASDAQ:TNYATenaya Therapeutics Inc
      09/29/20227:45AMGlobeNewswire Inc.Tenaya Therapeutics to Participate in Upcoming October Investor and Industry ConferencesNASDAQ:TNYATenaya Therapeutics Inc
      09/09/20227:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TNYATenaya Therapeutics Inc
      09/06/20224:05PMGlobeNewswire Inc.Tenaya Therapeutics to Participate in Upcoming September Investor ConferencesNASDAQ:TNYATenaya Therapeutics Inc
      09/06/202210:05AMTipRanksH.C. Wainwright Sticks to Their Buy Rating for Tenaya Therapeutics (TNYA)NASDAQ:TNYATenaya Therapeutics Inc
      09/06/20228:00AMGlobeNewswire Inc.Tenaya Therapeutics Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301, an HDAC6 Inhibitor for Heart Failure with Preserved Ejection FractionNASDAQ:TNYATenaya Therapeutics Inc
      08/18/20226:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TNYATenaya Therapeutics Inc
      08/17/20224:21PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TNYATenaya Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:TNYA